NCT00831844 2015-03-30Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed116 enrolled 8 charts
NCT00753415 2015-03-17A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)Merck Sharp & Dohme LLCPhase 1 Completed37 enrolled 10 charts